바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

logo

  • P-ISSN2287-8696
  • E-ISSN2288-744X
  • KCI

부인과 질환에 대한 金匱要略』 桂枝茯苓丸의 임상 연구 동향

Clinical research trends of JinGuiYaoLüe Gyejibokryeong-hwan for gynecological diseases

대한상한금궤의학회지 / The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe, (P)2287-8696; (E)2288-744X
2024, v.16 no.1, pp.1-20
https://doi.org/10.22891/KMEDIA.2024.16.1.1
최현범 (화목한휴일한의원)
이숭인 (동신대학교 한의과대학 방제학교실)

Abstract

Purpose: This study analyzes the clinical research findings of Gyejibokryeonghwan (GBH), an herbal formula for treating gynecological diseases in 『Jinguiyaolue』, and aims to verify the clinical evidence regarding its efficacy and safety. Methods: Clinical reports on treating gynecological diseases with GBH were collected from RISS, NAVER, KISS, OASIS, PUBMED, and Science Direct. The compiled literature was assessed by disease and research method, and the primary findings were summarized and considered. Results: Overall, 37 reports were classified by disease: five on uterine leiomyoma; two on polycystic ovary syndrome; two on chronic pelvic peritonitis or unspecified pelvic inflammatory disease; four on endometriosis; nine on primary, secondary, and unexplained dysmenorrhea; 13 on menopause and menopausal status; one on female infertility; and one undetermined. GBH’s therapeutic effect on these diseases was confirmed, and no serious side effects were reported. Furthermore, when GBH is administered with modern medicines for existing gynecological diseases, it enhances treatment efficacy and reduces side effects. Conclusion: GBH is a safe and effective herbal medicine for treating the aforementioned gynecological diseases with minimal side effects.

keywords
Gyejibokryeong-hwan, uterine fibroids, uterine leiomyoma, polycystic ovary syndrome, chronic pelvicitis, endometriosis, menstrual pain, menopausal condition

대한상한금궤의학회지